4-methyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one

InChIKey	`UQYNRUGJGAGAFC-QVMZXLCESA-N`
Compound Name	4-methyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one
Canonical SMILES	`Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)ccc12`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	6.32
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	7.0	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.2	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.2	pIC50	TTD_MultiTarget
Q16790	CA9	Homo sapiens	Human	PF00194	6.1	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	6.1	Ki	ChEMBL;BindingDB